GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
63 hedge funds and large institutions have $81.6M invested in Aevi Genomic Medicine Inc in 2015 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 9 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
63
Holding in Top 10
1
Calls
$284K
Puts
–
Top Buyers
| 1 | +$9.03M | |
| 2 | +$5.46M | |
| 3 | +$5.42M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$4.61M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.61M |
Top Sellers
| 1 | -$614K | |
| 2 | -$541K | |
| 3 | -$37.5K | |
| 4 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
-$13.2K |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$10.5K |